Ayush Blogs

  Rising PCI procedures, wider adoption of newer-generation stents, and growing demand for complex coronary interventions are supporting market expansion. November 3, 2026 — The global drug eluting stent market is projected to increase from USD 9.5 billion in 2026 to USD 15.8 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.2%, according to Fact.MR. The market was valued at USD 8.9 billion in 2025. Continued demand for coronary revascularization procedures and the adoption of newer-generation drug-eluting stent technologies are expected to create an absolute dollar opportunity of USD 6.3 billion over the forecast period. The expansion reflects the continued importance of drug-eluting stents in treating coronary artery disease (CAD). Hospitals and interventional cardiology centers remain the primary demand centers, particularly as physicians address complex coronary lesions and manage patients requiring different antiplatelet therapy strategies. Get de...

  Rising demand for dental restoration and joint replacement procedures is driving the osseointegration implants market, projected to expand at an 8.0% CAGR through 2036. November 3, 2026 The global osseointegration implants market is projected to reach USD 6.85 billion by 2036, increasing from USD 3.17 billion in 2026, according to Fact.MR. The market, valued at USD 2.94 billion in 2025, is expected to expand at a CAGR of 8.0% between 2026 and 2036. Growing demand for dental restoration and orthopedic replacement procedures is supporting this expansion as hospitals and dental clinics increase their use of bone-integrated implant systems. The outlook reflects a growing need for reliable implant solutions. Dental implants are gaining importance in crown and fixed denture procedures, while knee and hip replacement surgeries continue to support orthopedic demand. China is projected to record the fastest growth among the countries covered, with a 12.0% CAGR through 2036. Get de...

  The wireless handheld ultrasound devices market is projected to grow at a 16.3% CAGR through 2036, driven by point-of-care imaging demand, product innovation, and expanding healthcare access. November 3, 2026 — The global Wireless Handheld Ultrasound Devices Market is projected to increase from USD 1.3 billion in 2026 to USD 5.9 billion by 2036, expanding at a compound annual growth rate (CAGR) of 16.3% during the forecast period, according to Fact.MR. The market, valued at approximately USD 1.2 billion in 2025, is expected to create an absolute dollar opportunity of USD 4.6 billion between 2026 and 2036. Growing demand for portable diagnostic imaging, improvements in wireless connectivity, and wider adoption of point-of-care ultrasound are supporting this expansion. Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=6940 Wireless Handheld Ultrasound Devices Market Growth Drivers and Indu...

  Global automated breast ultrasound system market is projected to grow at 7.1% CAGR through 2036, driven by dense breast screening requirements and AI-assisted imaging. November 3, 2026 The global automated breast ultrasound system (ABUS) market is projected to reach USD 2.1 billion by 2036, increasing from USD 980.0 million in 2025 at a compound annual growth rate (CAGR) of 7.1%, according to Fact.MR. The market is estimated to reach USD 1.0 billion in 2026, creating an absolute dollar opportunity of approximately USD 1.0 billion between 2026 and 2036. Growing demand for supplemental breast cancer screening, particularly among women with dense breast tissue, is supporting procurement across hospitals and diagnostic imaging centers. Automated breast ultrasound systems produce standardized, reproducible three-dimensional volumetric images of breast tissue for screening and diagnostic assessment. Unlike conventional handheld ultrasound, ABUS platforms automate probe positionin...

  November 2, 2026 — The global viral vector production (research-use) market is estimated at USD 2.17 billion in 2026 and is projected to reach USD 8.35 billion by 2036, expanding at a compound annual growth rate (CAGR) of 14.4% during the forecast period, according to Fact.MR. The market was valued at approximately USD 1.9 billion in 2025. Growing investment in biotechnology research, increasing demand for viral vector-based studies, and expanding institutional production capabilities are supporting market expansion. The market is expected to generate an incremental opportunity of USD 6.18 billion between 2026 and 2036. Viral vectors will remain the leading product type, accounting for 52.7% of product demand in 2026. Upstream processing services are projected to represent 29.8% of the service type segment, while academic and research institutes will account for 45.9% of end-use demand. Get detailed market forecasts, competitive benchmarking, and pricing trends: https://ww...

  November 2, 2026 — The global viral vector production (research-use) market is estimated at USD 2.17 billion in 2026 and is projected to reach USD 8.35 billion by 2036, expanding at a compound annual growth rate (CAGR) of 14.4% during the forecast period, according to Fact.MR. The market was valued at approximately USD 1.9 billion in 2025. Growing investment in biotechnology research, increasing demand for viral vector-based studies, and expanding institutional production capabilities are supporting market expansion. The market is expected to generate an incremental opportunity of USD 6.18 billion between 2026 and 2036. Viral vectors will remain the leading product type, accounting for 52.7% of product demand in 2026. Upstream processing services are projected to represent 29.8% of the service type segment, while academic and research institutes will account for 45.9% of end-use demand. Get detailed market forecasts, competitive benchmarking, and pricing trends: https://ww...